KATHMANDU: The Department of Drug Administration has given permission for emergency use of the vaccine COVISHIELD against Covid-19 in Nepal.
The department has given conditional permission for the emergency use of the vaccine produced by the Serum Institute of India.
Covishield is an Indian version of the vaccine jointly developed by Oxford University and AstraZeneca. Two days before, the Department had published a notice for the registration of vaccines to be used for emergency use in Nepal.
India has already approved the vaccine for emergency use.
